1 |
S. J. Cho, "Recent development of search algorithm on small molecule docking", J. Chosun Natural Sci., Vol. 2, pp. 55-58, 2009.
과학기술학회마을
|
2 |
S. J. Cho, "Search space reduction techniques in small molecular docking." J. Chosun Natural. Sci., Vol. 3, pp. 143-147, 2010.
과학기술학회마을
|
3 |
S.J. Cho, "Calculation and application of partial charges", J. Chosun Natural Sci., Vol. 3, pp. 226-230, 2010.
과학기술학회마을
|
4 |
S.J. Cho, "Meaning and definition of partial charges", J. Chosun Natural Sci., Vol. 3, pp. 231-236, 2010.
과학기술학회마을
|
5 |
M. K. P. Andrew, B. A. James, S. Sen, W. Chen, Y. Xu, E. Sullivan, L. Li, K. Greenman, T. Charvat, D. Hansen, J. D. Daniel, J. J. K. Wright, and P. Zhang, "1-(4-Phenylpiperazin-1-yl_-2-(1H-Pyrazol-1-yl) ethanones as novel CCR1 antagonists". Biorganic & Medicinal Chemistry Letters, Vol. 23, pp. 1228-1231, 2013.
DOI
ScienceOn
|
6 |
C. G. Gadhe, T. Madhavan, G. Kothandan, and S. J. Cho, "In silico quantitative structure-activity relationship studies on P-gp modulators of tetrahydroisoquinoline-ethyl-phenylamine series", BMC Struct. Biol., Vol. 11, p. 5, 2011.
DOI
ScienceOn
|
7 |
F. L. Mendonaca, P. C. A. Fonseca, R. M. Phillips, J. W. Saldanha, T. J. Willliams, and J. E. Pease "Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist", J. Biol. Chem., Vol. 280, pp. 4808-4816, 2005.
DOI
ScienceOn
|
8 |
N. Vaidehi, S. Schlyer, R. J. Trabanino, W. B. Floriano, R. Abrol, S. Sharma, M. Kochanny, S. Koovakat, L. Dunning, M. Liang, J. M. Fox, F. L. Mendonca, J. E. Pease, W. A. Goddard, and R. Horuk, "Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation". J. Biol. Chem., Vol. 281, pp. 27613-27620, 2006.
DOI
ScienceOn
|
9 |
W. J. Karpus, N. W. Lukas, B. L. McRae, R. M. Strieter, S.L. Kunkel, and S.D. Miller, "An important role for the chemokine macrophage inflammatory protein-1R in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis", J. Immunol., Vol. 155, pp. 5003-5010, 1995.
|
10 |
J. Hvas, C. Mclean, J. Justesen, G. Kannourakis, L. Steinman, J. R. Oksenberg, and C. C. A. Bernard, "Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions", Scand. J. Immunol., Vol. 46, pp. 195-203, 1997.
DOI
ScienceOn
|
11 |
P. Rathanaswami, M. Hachicha, M. Sadick, T.J. Schall, and S.R. McColl "Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts", J. Biol. Chem., Vol. 268, pp. 5834-5839, 1993.
|
12 |
N. Snowden, A. Hajeer, W. Thomson, and B. Ollier, "RANTES role in rheumatoid arthritis", Lancet, Vol. 343, pp. 547-548, 1994.
|
13 |
A. E. Koch, S. L. Kunkel, and R. M. Strieter, "Cytokine in rheumatoid arthritis", J. Invest. Med., Vol. 43, pp. 28-38, 1995.
|
14 |
S. P. Raychauldhuri, W. Y. Jiang, E. M. Farber, T. J. Schall, M.R. Ruff, and C.B. Pert "Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis", Acta Derm. Venereol., Vol. 79, pp. 9-11, 1999.
DOI
|
15 |
G. Kothandan, T. Madhavan, C.G. Gadhe, and S.J. Cho, "Pseudoreceptor: concept and an overview", J. Chosun Natural Sci., Vol. 3, pp. 162-167, 2010.
과학기술학회마을
|
16 |
P. M. Murphy, M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L.H. Miller, J.J. Oppenheim, and C. A. Power, "International union of pharmacology. XXII. Nomenclature for chemokine receptors", Pharmacol. Rev., Vol. 52, pp. 145- 176, 2000.
|
17 |
P. M. Murphy "International union of pharmacology. XXX. Update on chemokine receptor nomenclature", Pharmacol. Rev., Vol. 54, pp. 227-229, 2002.
DOI
ScienceOn
|
18 |
W. J. Moree, K. I. Kataoka, M. M. Ramirez-Weinhouse, T. Shiota, M. Imai, M. Sudo, and T. Tsutsumi, "Small molecule antagonists of the CCR2b receptor. Part 2: discovery process and initial structure-activity relationships of diamine derivatives", Bioorg. Med. Chem. Lett., Vol. 14, pp. 5413-5416, 2004.
DOI
ScienceOn
|
19 |
A. Zlotnik and O. Yoshie "Chemokines: a new classification review system and their role in immunity". Immunity. Vol. 12, pp. 121-127, 2000.
DOI
ScienceOn
|
20 |
M. Imai, T. Shiota, K. Kataoka, C. M. Tarby, W. J. Moree, T. Tsutsumi, and M. Sudo, "Small molecule inhibitors of the CCR2b receptor. Part 1: discovery and optimization of homopiper-azine derivatives", Bioorg. Med. Chem. Lett., Vol. 14, pp. 5407-5411, 2004.
DOI
ScienceOn
|
21 |
S. P. Weisberg, D. Hunter, R. Huber, J. Lemieux, S. Slaymaker, K. Vaddi, I. Charo, R. L. Leibel, and A.W. Jr. Ferrante, "CCR2 modulates inflammatory and metabolic effects of high-fat feeding", J. Clin. Invest., Vol. 116, pp. 115-124, 2006.
DOI
ScienceOn
|
22 |
C. Rolland, R. Gozalbes, E. Nicolai, M.F. Paugam, L. Coussy, F. Barbosa, D. Horvath, and F. Revah, "G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation". J. Med. Chem., Vol. 48, pp. 6563-6574, 2005.
DOI
ScienceOn
|
23 |
T. A. Berkhout, F. E. Blaney, A. M. Bridges, D. G. Cooper, I. T. Forbes, A. D. Gribble, P.H.E. Groot, A. Hardy, R. J. Ife, R. Kaur, K. E. Moores, H. Shillito, J. Willetts, J. Witherington, "CCR2: Characterization of the antagonist binding site from a combinedreceptor modelingmutagenesis approach", J. Med. Chem., Vol. 46, pp. 4070-4086, 2003.
DOI
ScienceOn
|
24 |
T. G. Marshall, R. E. Lee, and F. E. Marshall "Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b". Theor. Biol. Med. Model., Vol. 3, p. 1, 2006.
DOI
ScienceOn
|
25 |
C. Gerard and B. J. Rollins "Chemokines and disease". Nat. Immunol., Vol. 2, pp. 108-115, 2001.
DOI
ScienceOn
|
26 |
S, Segerer, P. J, Nelson, and D. Scholondorff, "Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies", J. Am. Soc. Nephrol., Vol. 11, pp. 152-176, 2000.
|
27 |
T. Mirzadegan, F. Diehl, B. Ebi, S. Bhakta, I. Polsky, D. McCarley, M. Mulkins, G.S. Weatherhead, J.M. Lapierre, J. Dankwardt, D. Jr Morgans, R. Wilhelm, and K. Jarnagin 'Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle", J. Biol. Chem., Vol. 275, pp. 25562-25571, 2000.
DOI
ScienceOn
|
28 |
C. L. Tsou, W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, and I.F. Charo "Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites", J. Clin. Invest., Vol. 117, pp. 90-909, 2007.
|
29 |
M. Baggiolini, "Chemokines and leukocyte traffic", Nature, Vol. 392, pp. 565-568, 1998.
DOI
ScienceOn
|
30 |
A. D. Luster, "Chemokines: chemotactic cytokines that mediate inflammation", N. Engl. J. Med., Vol. 338, pp. 436-445, 1998.
DOI
ScienceOn
|